Structure Therapeutics Inc
GPCR17.330USD
-0.260-1.48%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
2.99BMarket Cap
LossP/E TTM
Structure Therapeutics Inc
17.330
-0.260-1.48%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q2
FY2022Q1
FY2021Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-53.25%-52.23M
-67.83%-36.47M
4.19%-19.70M
-56.23%-26.39M
-67.82%-34.08M
-80.68%-21.73M
---20.56M
-67.35%-16.89M
-50.23%-20.31M
-11.78%-12.03M
---10.10M
---13.52M
---10.76M
Net income from continuing operations
-79.88%-46.83M
-48.88%-36.48M
-42.39%-33.98M
-11.83%-26.03M
-44.85%-26.04M
-106.34%-24.50M
---23.86M
-66.91%-23.28M
-37.41%-17.98M
11.09%-11.88M
---13.95M
---13.08M
---13.36M
Operating gains losses
23.42%274.00K
279.17%273.00K
235.44%265.00K
213.51%232.00K
217.14%222.00K
0.00%72.00K
--79.00K
25.42%74.00K
0.00%70.00K
9.09%72.00K
--59.00K
--70.00K
--66.00K
Other non-cash items
-68.55%-4.79M
-162.54%-5.56M
-312.27%-5.71M
-76.93%-2.75M
-983.59%-2.84M
-426.62%-2.12M
---1.39M
-2020.99%-1.56M
-469.01%-262.00K
-682.61%-402.00K
--81.00K
--71.00K
--69.00K
Change in working capital
16.74%-6.80M
-119.63%-534.00K
397.75%13.70M
-132.99%-2.03M
-74.82%-8.17M
712.84%2.72M
--2.75M
100.85%6.17M
-290.15%-4.67M
-129.11%-444.00K
--3.07M
---1.20M
--1.52M
-Change in prepaid expenses
23.83%-5.05M
138.40%672.00K
337.44%2.14M
45.30%2.41M
-117.60%-6.63M
-654.31%-1.75M
---900.00K
285.67%1.66M
-3039.18%-3.04M
-154.95%-232.00K
---893.00K
---97.00K
---91.00K
-Change in other current assets
-49400.00%-990.00K
-46814.29%-3.28M
--4.00K
-2296.30%-1.78M
96.61%-2.00K
88.33%-7.00K
--0.00
--81.00K
---59.00K
-66.67%-60.00K
----
----
---36.00K
Cash from non-recurring investing activities
Cash from operating activities
-53.25%-52.23M
-67.83%-36.47M
4.19%-19.70M
-56.23%-26.39M
-67.82%-34.08M
-80.68%-21.73M
---20.56M
-67.35%-16.89M
-50.23%-20.31M
-11.78%-12.03M
---10.10M
---13.52M
---10.76M
Investing cash flow
Net cash from continuing investing activities
93.83%314.00K
-98.62%16.00K
-16.46%685.00K
123.56%427.00K
--162.00K
1528.17%1.16M
--820.00K
460.38%191.00K
-100.00%0.00
-40.83%71.00K
---53.00K
--65.00K
--120.00K
Capital expenditures
93.83%314.00K
-98.62%16.00K
-16.46%685.00K
123.56%427.00K
--162.00K
1528.17%1.16M
--820.00K
--191.00K
-100.00%0.00
-40.83%71.00K
----
--65.00K
--120.00K
Net cash flow from disposal of fixed assets
93.83%314.00K
-98.62%16.00K
-16.46%685.00K
123.56%427.00K
--162.00K
1528.17%1.16M
--820.00K
460.38%191.00K
-100.00%0.00
-40.83%71.00K
---53.00K
--65.00K
--120.00K
Net cash flow from investment products
2073.86%34.35M
118.51%33.25M
-708.61%-188.36M
-197.85%-204.09M
103.22%1.58M
-1824.82%-179.59M
--30.95M
-324.88%-68.52M
-23.61%-49.02M
767.67%10.41M
---16.13M
---39.65M
--1.20M
Cash from non-current investing activities
Net cash flow from investing activities
2300.07%34.03M
118.39%33.23M
-727.45%-189.04M
-197.65%-204.51M
102.89%1.42M
-1847.84%-180.74M
--30.13M
-327.47%-68.71M
-23.41%-49.02M
857.50%10.34M
---16.07M
---39.72M
--1.08M
Financing cash flow
Cash flow from continuous financing activities
15.24%809.00K
-99.78%615.00K
-260.04%-757.00K
173400.67%514.70M
-99.59%702.00K
89223.10%281.63M
--473.00K
-100.96%-297.00K
11821.41%169.73M
-174.78%-316.00K
--31.04M
---1.45M
---115.00K
Net cash flow from common stock issuance/repurchase
----
-100.00%0.00
--0.00
--514.57M
----
--300.00M
--0.00
--0.00
--172.30M
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
--0.00
----
----
----
--0.00
--31.50M
----
--0.00
Proceeds from stock option exercised by employees
27.81%965.00K
425.64%615.00K
-16.07%397.00K
301.68%719.00K
2335.48%755.00K
--117.00K
--473.00K
--179.00K
--31.00K
--0.00
----
----
--0.00
Net cash flow from other financing activities
-194.34%-156.00K
100.00%0.00
---1.15M
-23.74%-589.00K
97.96%-53.00K
-5750.63%-18.49M
--0.00
-2.81%-476.00K
-79.63%-2.60M
-174.78%-316.00K
---463.00K
---1.45M
---115.00K
Net cash from non-recurrent financing activities
Net cash from financing activities
15.24%809.00K
-99.78%615.00K
-260.04%-757.00K
173400.67%514.70M
-99.59%702.00K
89223.10%281.63M
--473.00K
-100.96%-297.00K
11821.41%169.73M
-174.78%-316.00K
--31.04M
---1.45M
---115.00K
Net cash flow
Beginning cash balance
30.60%169.51M
239.94%172.13M
840.18%381.63M
-22.66%97.83M
397.46%129.79M
80.25%50.64M
--40.59M
149.88%126.49M
-75.22%26.09M
-75.59%28.09M
--50.62M
--105.31M
--115.10M
Current period cash flow changes
45.60%-17.39M
-103.31%-2.62M
-2185.58%-209.50M
430.37%283.80M
-131.83%-31.96M
4055.82%79.16M
--10.04M
-1864.63%-85.90M
283.60%100.40M
79.57%-2.00M
--4.87M
---54.68M
---9.79M
Ending cash balance
55.49%152.12M
30.60%169.51M
239.94%172.13M
840.18%381.63M
-22.66%97.83M
397.46%129.79M
--50.64M
-26.85%40.59M
149.88%126.49M
-75.22%26.09M
--55.49M
--50.62M
--105.31M
Free cash flow
-53.45%-52.54M
-59.42%-36.48M
4.66%-20.38M
-56.98%-26.82M
-68.61%-34.24M
-89.18%-22.89M
---21.38M
-69.24%-17.09M
-49.51%-20.31M
-11.20%-12.10M
---10.10M
---13.58M
---10.88M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
